Nature Communications (Dec 2017)
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
Abstract
Most melanoma patients do not respond to anti-PD1 therapy. Here, the authors show that TNFα blockade synergizes with anti-PD-1 by preventing anti-PD-1-induced CD8+ T cell death and TIM-3 expression on such cells.
